Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 17 18 19 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
F-Star–Hume Brophy: public relations, 201604 service existent by Hume Brophy London 2016-04-21
Enterome–BPCE: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Seventure Partners 2016-04-20
Enterome–Lundbeck: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Lundbeckfond Ventures 2016-04-20
Enterome–Nestlé: investment, 201604 financing round Series C totalling €14.5m incl new + co-investor Nestlé Health Science 2016-04-20
Enterome–SEVERAL: investment, 201604 financing round Series C €14.5m led by Seventure Partners + Lundbeckfond Ventures plus Nestlé Health et al 2016-04-20
Second Genome–Roche: investment, 201604 financing round Series B totalling $42.6m co-led by Pfizer Venture Investments + Roche Venture Fund 2016-04-20
Second Genome–SEVERAL: investment, 201604 financing round Series B $42.6m co-led by Pfizer Venture Investments + Roche Venture Fund 2016-04-20
Univ Lausanne–Saphetor: bioinformatics, 201604– supply CHUV to use Saphetor’s precision medicine platform for research + clinical applications 2016-04-20
G-Therapeutics–Gimv: investment, 201604 financing round Series A totalling €26m incl co-investor Gimv 2016-04-19
G-Therapeutics–Netherlands (govt): credit, 201604 deferred risk-bearing innovation loan €10m from RvO 2016-04-19
G-Therapeutics–SEVERAL: investment, 201604 financing round Series A €26m co-led by LSP + INKEF Capital + Gimv + Wellington Partnes 2016-04-19
HMNC–R-Biopharm: molecular companion diagnostics, 201604– collab €na developm PCR-based ABCB1 CDx for depression therapy 2016-04-19
Minapharm–Eucodis: ADC technology, 201604– license excl for C-LiNK (CTAT) technology to ProBioGen 2016-04-19
Pierre Fabre–Evotec: compound management, 201604–201103 supply service €na sample management for Pierre Fabre by Evotec Toulouse 2016-04-19
Hopp Group–Promethera: investment, 201604 acquisition of key assets of Cytonet in shares w Hopp family holding up to 13% of Promethera afterwards 2016-04-18
Promethera–Hopp Group: investment, 201604 Hopp family holding up to 13% of Promethera after sale of key assets of Cytonet to Promethera 2016-04-18
Crelux–WuXi PharmaTech: investment, 201604 acquisition of Crelux GmbH by WuXi AppTec 2016-04-15
Agena Bioscience–Horizon Discovery: reference standards, 201604– supply + distribution agreem for iPLEX standards for MassARRAY oncology assays 2016-04-14
GeNeuro–SEVERAL: investment, 201604 IPO €33m+€1k IPO with 2.54m+9.4k new shares at Euronext Paris 2016-04-14
Mirati–Qiagen: molecular companion diagnostics, 201604– collab developm + commercialisation of RNA-based CDx for glesatinib 2016-04-13
Forbion–SEVERAL: investment, 201604 final closing €183m of FCF III Fund incl EIF + DVI + FkW + Charles River Labs + Knight Therapeutics 2016-04-12
KWS Saat–HZPC: investment, 201604 acquisition €na of conventional seed potato business of KWS by Stet Holland BV 2016-04-11
STAT-Diagnostica–Boehringer: investment, 201604 financing round Series C totalling €25m incl returning co-investor BIVF 2016-04-11
STAT-Diagnostica–Gilde Investment: investment, 201604 financing round Series C totalling €25m incl led + new investor Gilde Healthcare 2016-04-11
STAT-Diagnostica–SEVERAL: investment, 201604 financing round Series C €25m led by new investor Gilde Healthcare 2016-04-11
United States (govt)–Evolva: biomaterials, –201604 collab CRADA to develop new materials for the US Navy 2016-04-11
Cunesoft–Bavaria (govt): investment, 201604 financing round Series A 7-digit €na incl returning co-investor Bayern Kapital 2016-04-07
Cunesoft–High-Tech Gründerfonds: investment, 201604 financing round Series A 7-digit €na incl returning co-investor HTGF 2016-04-07
Cunesoft–Occident Group: investment, 201604 financing round Series A 7-digit €na incl new + lead investor Occident Group AG 2016-04-07
Cunesoft–SEVERAL: investment, 201604 financing round Series A 7-digit €na led by Occident Group + incl HTGF + Bayern Kapital 2016-04-07
Bayer–Meiogenix: plant breeding technology, 201604– license non-excl €na to SpiX technology for Bayer CropScience 2016-04-06
Lumos Pharma–Roche: investment, 201604 financing round Series B totalling $34m incl new co-investor Roche Venture Fund 2016-04-06
Lumos Pharma–SEVERAL: investment, 201604 financing round Series B $34m led by Deerfield Management Co plus Roche VF + UCB et al 2016-04-06
Lumos Pharma–UCB: investment, 201604 financing round Series B totalling $34m incl existing + co-investor UCB 2016-04-06
Thermosome–Bavaria (govt): investment, 201604 1st financing round totalling €1.9m incl HTGF + Bayern Kapital + private investors 2016-04-06
Thermosome–Germany (govt): grant, 201604– BMBF grant €2.7m 3y as part of TSL-LIFU project consortium 2016-04-06
Thermosome–High-Tech Gründerfonds: investment, 201604 1st financing round totalling €1.9m incl HTGF + Bayern Kapital + private investors 2016-04-06
Thermosome–SEVERAL: investment, 201604 1st financing round €1.9m from HTGF + Bayern Kapital + private investors 2016-04-06
Qiagen–BioTeam: bioinformatics, 201604 collab existent to create high-performance appliance with CLC Genomics Server + BioTeam Appliance platform 2016-04-05
Qiagen–Intel: bioinformatics, 201604 collab existent to develop reference architecture for high-volume whole genome data analysis 2016-04-05
Anergis–SEVERAL: investment, 201604 financing round extension CHF5m to conduct phase 2b study with AllerT from existing investors 2016-04-04
Immunocore–Medigene: investment, 201604 DIVESTMENT sale of 50% of Medigene’s stake in Immunocore for £4.9m (€6.1m) 2016-04-04
Metabomed–Boehringer: investment, 201604 financing round Series A totalling $18m incl investors MS Ventures + BIVF et al 2016-04-04
Metabomed–Merck (DE): investment, 201604 financing round Series A totalling $18m incl investors MS Ventures + BIVF et al 2016-04-04
Metabomed–SEVERAL: investment, 201604 financing round Series A extension bringing total Series A round to close with $18m 2016-04-04
Fusion Antibodies–MAB Discovery: antibody technology, 201603– collab + license use CDRx humanisation w rabbit-based MAb technology for therap MAbs 2016-03-31
NEO New Oncology–Siemens: investment, 201603 acquisiton by Siemens Healthcare GmbH 2016-03-31
Amal Therapeutics–Boehringer: investment, 201603 financing round Series A totalling CHF3m incl lead investor BIVF 2016-03-30
Amal Therapeutics–High-Tech Gründerfonds: investment, 201603 financing round Series A totalling CHF3m incl co-investor HTGF 2016-03-30
Amal Therapeutics–Instinctif Partners: public relations, 201603 service existent by Instinctif Partners 2016-03-30
Amal Therapeutics–SEVERAL: investment, 201603 financing round Series A CHF3m led by BIVF with co-investors VI Partners + HTGF 2016-03-30
Amal Therapeutics–VI Partners: investment, 201603 financing round Series A totalling CHF3m incl co-investor VI Partners 2016-03-30
BioChain–Epigenomics: molecular diagnostics, 201603– license excl blood-based lung cancer test for developm + commercialisation in China 2016-03-30
Zavante Therapeutics–SEVERAL: investment, 201603 financing round Series A $45m with $35m from new investors + $10m conversion of convertible notes 2016-03-30
Exiqon–Qiagen: investment, 201603–201606 conditional voluntary takeover offer DKK683m ($100m) 2016-03-29
Gadeta–SEVERAL: investment, 201603 financing round Series A €7m led by Medicxi Ventures + Baxalta Ventures with Utrecht Holdings + founders + managers 2016-03-29
ABBA Therapeutics–Ligand: transgenic animal technology, 201603– license to use OmniAb platform to develop MAbs + bi-specific ABs 2016-03-28
Bayer–Holta Invest: investment, 201603 existent Bayer listed as portfolio company of Holta Life Sciences 2016-03-28
Roche–Holta Invest: investment, 201603 existent Roche listed as portfolio company of Holta Life Sciences 2016-03-28
Diatron–Stratec: investment, 201603 acquisition 100% of Diatron MI PLC by Stratec from The Riverside Company 2016-03-23
Padlock Therapeutics–BMS: investment, 201603–201604 acquisition 100% for up to $600m 2016-03-23
Thuringia (govt)–High-Tech Gründerfonds: venture capital, 201603– collab renewed TSF + HTGF to jointly provide up to €3.15m for early financings 2016-03-23
Topas Therapeutics–EMBL: investment, 201603 financing round Series A totalling €14m incl co-investor EMBL Ventures 2016-03-22
Topas Therapeutics–Epidarex Capital: investment, 201603 financing round Series A totalling €14m led by Epidarex 2016-03-22
Topas Therapeutics–Evotec: investment, 201603 financing round Series A totalling €14m incl co-investor Evotec AG 2016-03-22
Topas Therapeutics–Gimv: investment, 201603 financing round Series A totalling €14m incl €4m from co-investor Gimv Health & Care 2016-03-22
Topas Therapeutics–SEVERAL: investment, 201603 financing round Series A €14m led by Epidarex incl EMBL Ventures + Gimv + Evotec 2016-03-22
GSK–Miltenyi Biotec: cell/gene therapy, 201603– collab cell + gene therapy incl CAR-T using increased automation 2016-03-16
SkyePharma–Vectura: investment, 201603– acquisition merger £441m in shares (up to £70m cash) resulting in 41.75% (37.62%) for former Skye owners 2016-03-16
Almirall–Grünenthal: investment, 201603– acquisition 100% of Almirall de Mexico SA de CV by Grünenthal ANNNOUNCED 2016-03-15
Bohui–Univ Freiburg: mass spec sample introduction technique, –201603 collab developm iASAP Prof Krossing + license of patent rights to Advion 2016-03-15
Roche–Blueprint Medicines: kinase inhibitors, 201603– collab ww $45m upfront + $965m milestones r+d + commerc up to 5 small molelcule drugs 2016-03-15
eTheRNA–Boehringer: investment, 201603 financing round Series A totalling €24m incl co-investor BIVF 2016-03-14
eTheRNA–Flanders (govt): investment, 201603 financing round Series A totalling €24m led by PMV + Life Sciences Partners 2016-03-14
eTheRNA–Fund+: investment, 201603 financing round Series A totalling €24m incl co-investor Fund+ 2016-03-14
eTheRNA–Life Sciences Partners: investment, 201603 financing round Series A totalling €24m led by Life Sciences Partners + PMV 2016-03-14
eTheRNA–Omega Advisors: investment, 201603 financing round Series A totalling €24m incl co-investor Omega Funds 2016-03-14
eTheRNA–SEVERAL: investment, 201603 financing round Series A €24m led by Life Sciences Partners + PMV 2016-03-14
Agilent–Eurofins: genomic technology, 201603– collab Eurofins Genomics supplies custom components for Agilent’s SureVector cloning kits 2016-03-10
Aprea–MC Services: public relations, 201602 service existent for Aprea AB 2016-03-09
AbbVie–Boehringer: therap antibodies, 201603– collab + acqu ww rights BI 655066 + BI 655064 for $595m upfront + undisclosed milestones + royalties 2016-03-07
Argos–SEVERAL: investment, 201603– securities purchase agreem up to $60m common stock + warrants in 3 tranches incl Pharmstandard + TVM 2016-03-07
ITM Isotopen Technologien München–OTHER: investment, 201603 equity investment €20m from Medtech-focused family office 2016-03-07
Biocom–Nasdaq OMX: press release distribution, 201603 collab existent integration of channel news in Eurobiotechnews.eu portal 2016-03-06
Snowy Range Instruments–Metrohm: investment, 201603 acquisition of majority by Metrohm + SnRI renamed Metrohm Raman 2016-03-04
Biolink (NO)–Evonik: investment, 201603 acquisition €na of MedPalett AS by Evonik from Biolink Group 2016-03-03
Grünenthal–Axxam: drug discovery services, 201603– collab to discover small moleucule lead structures to treat pain + inflammation 2016-03-03
Pulsar Photonics–High-Tech Gründerfonds: investment, 201603 seed financing from HTGF 2016-03-02
Cycle GmbH–Hamburg (govt): investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–High-Tech Gründerfonds: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–PERSON: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–SEVERAL: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Merck (DE)–EMBL: drug discovery, 201603–201902 collab research 3y with EMBL Heidelberg w focus on cancer metabolism 2016-03-01
Retina Implant–SEVERAL: investment, 201602 private equity funding round €26m from existing + new investors 2016-02-29
CPGR (ZA)–Thermo Fisher: mass spectrometer, 201602 supply existent Q Exactive MS system used for proteomics 2016-02-26
Blue Scientific–Accurion: laboratory instruments, 201602– distribution Nanofilm Technology + Halcyonics products in UK + Nordics by Blue Scientific 2016-02-25
Pronutria–Nestlé: investment, 201602 equity investment $42.5m by Nestlé Health Science 2016-02-23
Ergomed–MC Services: public relations, 201602 service existent for Ergomed plc 2016-02-18
MorphoSys–MC Services: public relations, 201602 service existent for MorphoSys AG 2016-02-18
Newron–MC Services: public relations, 201602 service existent for Newron Pharmaceuticals 2016-02-18
next pagenext page 1 2 3 ... 17 18 19 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top